Search PubMed⌕ Search

Biomedical subjects

A Farid

Publications and source records attributed to A Farid.

28 records · Page 2Linked to original sources
PubMed1979

Spectrum of Escherichia coli agglutinins in dam's sera, colostrum and calf's sera in Fresian cows and buffaloes in Egypt.

Sera collected from 18 pregnant buffaloes and Fresian cows during the last two weeks before parturition and from the newborn calves during the first two weeks after birth. All the samples together with the colostral whey of the first three days were examined for the presence of E. coli agglutinins using the tube agglutination and passive hemagglutination tests. The latter test was more sensitive and demonstrated higher titres in all cases, and consequently more O groups. Agglutinins to various E. coli O groups were detected in all samples. It is worthy to note that agglutinins to all E. coli O groups used as antigens were detected in 13 dam's sera, 17 colostrum and in one buffaloe calf. The titres were higher in colostrum than in dam's or calf's sera. The highest titre was 1:640. The O groups 101, 115, 117, and 26 were the most common among Fresian cows whereby the O groups 101 and 115 showed the highest titres. In buffaloes the O groups 101, 115, 8 and 26 were the most common with the O8 having the highest titre.

Agglutination Tests↗
PubMedDate not supplied

Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C.

A potent, long-lasting form of interferon alpha-2a mono-pegylated with a 40 kilodalton branched poly(ethylene glycol) was designed, synthesized, and characterized. Mono-pegylated interferon alpha-2a was comprised of four major positional isomers involving Lys31, Lys121, Lys131, and Lys134 of interferon. The in vitro anti-viral activity of pegylated interferon alpha-2a was found to be only 7% of the original activity. In contrast, the in vivo antitumor activity was severalfold enhanced compared to interferon alpha-2a. Pegylated interferon alpha-2a showed no immunogenicity in mice. After subcutaneous injection of pegylated interferon alpha-2a, a 70-fold increase in serum half-life and a 50-fold increase in mean plasma residence time concomitant with sustained serum concentrations were observed relative to interferon alpha-2a. These preclinical results suggest a significantly enhanced human pharmacological profile for pegylated interferon alpha-2a. Results of Phase II/III hepatitis C clinical trials in humans confirmed the superior efficacy of pegylated interferon alpha-2a compared to unmodified interferon alpha-2a.

Animals↗
PubMedDate not supplied

Carotid endarterectomy in patients with renal insufficiency: Should selection criteria be different in patients with renal insufficiency?

The objective of this study was to elucidate the relationship between outcomes from carotid endarterectomy (CEA) in patients with and without renal insufficiency. Carotid endarterectomy is one of the most commonly performed vascular procedures. The role of cardiac comorbidity in carotid endarterectomy has been extensively studied. The relationship between renal failure and surgical outcomes has also been studied for both coronary artery bypass grafting and lower extremity occlusive disease. However, the role of renal insufficiency in relationship to decision making regarding surgical intervention for carotid stenosis is not well defined. The authors hypothesized that the outcomes from CEA were negatively influenced by renal dysfunction. A retrospective review was made of consecutive CEAs performed at their institution from 1990 to 1995. Patients were grouped into 2 categories according to their renal function. Group A, 448 patients (90%) with creatinine level 1.8 mg/dL or less, and group B, 49 patients (10%) with creatinine levels more than 1.8 mg/dL. Data from patients on dialysis are presented but were excluded for the purpose of analysis. Included in the study were 497 patients with a mean age of 70 +/-8.9 and 74 +/-8.9 for groups A and B, respectively. Preoperative creatinine was 1.1 (+/-0.25) mg/dL for group A and 2.5 (+/-0.81) mg/dL for group B. Outcomes were as follows: perioperative cardiac events 5.4% vs 28.6%, stroke rates 2.7% vs 2.0%, and mortality rates 0.9% vs 8.2%, for groups A and B, respectively. At 60-month follow-up the stroke rates were 7.6% vs 6.1 %, and the mortality rates 22.8% vs 59.2%, for groups A and B, respectively. While patients with chronic renal insufficiency have no increased risk of perioperative or long-term neurologic events, perioperative and long-term mortality rates are significantly increased. This significant reduction in survival should prompt a more cautious application of CEA in patients with increased creatinine.

Aged↗